# Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache

> **NCT05108688** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 210 (actual)

## Conditions studied

- Headache

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Sumatriptan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05108688
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-15
- **Primary completion:** 2023-12-20
- **Final completion:** 2023-12-20
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05108688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05108688, "Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05108688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*